BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21480192)

  • 1. Docking on the DNA G-quadruplex: a molecular electrostatic potential study.
    Mondragón-Sánchez JA; Santamaria R; Garduño-Juárez R
    Biopolymers; 2011 Sep; 95(9):641-50. PubMed ID: 21480192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
    Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
    J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
    Jain AK; Bhattacharya S
    Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological relevance of telomeric G-quadruplex formation: a potential drug target.
    Oganesian L; Bryan TM
    Bioessays; 2007 Feb; 29(2):155-65. PubMed ID: 17226803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the first parallel DNA quadruplex-drug complex.
    Clark GR; Pytel PD; Squire CJ; Neidle S
    J Am Chem Soc; 2003 Apr; 125(14):4066-7. PubMed ID: 12670225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-quadruplexes as therapeutic targets.
    Neidle S; Read MA
    Biopolymers; 2000-2001; 56(3):195-208. PubMed ID: 11745111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.
    Fedoroff OY; Salazar M; Han H; Chemeris VV; Kerwin SM; Hurley LH
    Biochemistry; 1998 Sep; 37(36):12367-74. PubMed ID: 9730808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [G-quadruplex DNA: myth or reality?].
    Riou JF; Gomez D; Lemarteleur T; Trentesaux C
    Bull Cancer; 2003 Apr; 90(4):305-13. PubMed ID: 12801813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duplex and quadruplex DNA binding and photocleavage by trioxatriangulenium ion.
    Pothukuchy A; Mazzitelli CL; Rodriguez ML; Tuesuwan B; Salazar M; Brodbelt JS; Kerwin SM
    Biochemistry; 2005 Feb; 44(6):2163-72. PubMed ID: 15697242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for investigating G-quadruplex DNA/ligand interactions.
    Murat P; Singh Y; Defrancq E
    Chem Soc Rev; 2011 Nov; 40(11):5293-307. PubMed ID: 21720638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay.
    Mergny JL; Lacroix L; Teulade-Fichou MP; Hounsou C; Guittat L; Hoarau M; Arimondo PB; Vigneron JP; Lehn JM; Riou JF; Garestier T; Hélène C
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3062-7. PubMed ID: 11248032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined QM and MM investigation into guanine quadruplexes.
    Clay EH; Gould IR
    J Mol Graph Model; 2005 Oct; 24(2):138-46. PubMed ID: 16168688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimeric 1,3-phenylene-bis(piperazinyl benzimidazole)s: synthesis and structure-activity investigations on their binding with human telomeric G-quadruplex DNA and telomerase inhibition properties.
    Jain AK; Paul A; Maji B; Muniyappa K; Bhattacharya S
    J Med Chem; 2012 Apr; 55(7):2981-93. PubMed ID: 22452380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermally induced DNA.RNA hybrid to G-quadruplex transitions: possible implications for telomere synthesis by telomerase.
    Salazar M; Thompson BD; Kerwin SM; Hurley LH
    Biochemistry; 1996 Dec; 35(50):16110-5. PubMed ID: 8973182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-quadruplexes: targets in anticancer drug design.
    Ou TM; Lu YJ; Tan JH; Huang ZS; Wong KY; Gu LQ
    ChemMedChem; 2008 May; 3(5):690-713. PubMed ID: 18236491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label-free electrochemical selection of G-quadruplex-binding ligands based on structure switching.
    Jin Y; Li H; Liu P
    Biosens Bioelectron; 2010 Aug; 25(12):2669-74. PubMed ID: 20488688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the structures of ligand-quadruplex complexes from molecular dynamics simulations.
    Hou JQ; Chen SB; Tan JH; Ou TM; Luo HB; Li D; Xu J; Gu LQ; Huang ZS
    J Phys Chem B; 2010 Nov; 114(46):15301-10. PubMed ID: 21049896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Template-assembled synthetic G-quadruplex (TASQ): a useful system for investigating the interactions of ligands with constrained quadruplex topologies.
    Murat P; Bonnet R; Van der Heyden A; Spinelli N; Labbé P; Monchaud D; Teulade-Fichou MP; Dumy P; Defrancq E
    Chemistry; 2010 May; 16(20):6106-14. PubMed ID: 20397247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
    Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
    J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA.
    Tan JH; Ou TM; Hou JQ; Lu YJ; Huang SL; Luo HB; Wu JY; Huang ZS; Wong KY; Gu LQ
    J Med Chem; 2009 May; 52(9):2825-35. PubMed ID: 19354252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.